Account Subscribe
Slate relies on advertising to support our journalism. If you value our work, please disable your ad blocker.
By joining Slate Plus you support our work and get exclusive content. And you'll never see this message again.
Big Pharma’s Attempt to Ghostwrite for Stat Ended Badly—but Not Badly Enough
Stat retracted the story, but for the wrong reasons and without addressing the real problem.